ClinicalTrials.Veeva

Menu

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Stanford University logo

Stanford University

Status

Completed

Conditions

Epidermolysis Bullosa Dystrophica

Study type

Observational

Funder types

Other

Identifiers

NCT00904163
SU-04232009-2383

Details and patient eligibility

About

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering disease caused by the absence of type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening RDEB subjects to determine additional characteristics of patients who survive to adulthood.

Enrollment

13 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:1. Clinical diagnosis of RDEB by local dermatologist. 2. 18 years of age or more and willing to give consent. Exclusion Criteria:1. Medical instability limiting ability to travel to Stanford University Medical Center.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems